{
    "hands_on_practices": [
        {
            "introduction": "The foundation of evaluating any diagnostic or screening test lies in its performance against a 'gold standard,' typically summarized in a $2 \\times 2$ contingency table. This first exercise  provides the results from a pilot screening program, allowing you to practice the essential skill of calculating a test's core operating characteristics. By working through this problem, you will compute sensitivity ($\\mathrm{Se}$), specificity ($\\mathrm{Sp}$), and their complements, the false positive rate ($\\mathrm{FPR}$) and false negative rate ($\\mathrm{FNR}$), which are the bedrock metrics of test evaluation.",
            "id": "4573913",
            "problem": "A public health department is piloting a screening program for a chronic condition using a rapid test and a validated reference standard. In a sample of $1000$ adults, the reference standard identifies cases and non-cases. Cross-classification of the rapid test results against the reference standard yields the following counts: True Positives (TP) $=180$, False Negatives (FN) $=20$, False Positives (FP) $=40$, and True Negatives (TN) $=760$. Using only core definitions from binary classification and conditional probability, compute the following operating characteristics of the test: sensitivity $\\mathrm{Se}$, specificity $\\mathrm{Sp}$, false positive rate $\\mathrm{FPR}$, and false negative rate $\\mathrm{FNR}$. Report each quantity as a decimal rounded to four significant figures, and provide your final numeric results as a quadruple in the order $\\left(\\mathrm{Se}, \\mathrm{Sp}, \\mathrm{FPR}, \\mathrm{FNR}\\right)$. Then, explain what each rate means in terms of the trade-off between missed cases and unnecessary follow-up among those screened. Express all rates as decimals (not percentages). Round your computed values to four significant figures.",
            "solution": "The operating characteristics of a diagnostic test are derived from a $2 \\times 2$ contingency table that cross-classifies the test results against a reference (or \"gold\") standard. The quantities provided are: True Positives ($\\mathrm{TP} = 180$), False Negatives ($\\mathrm{FN} = 20$), False Positives ($\\mathrm{FP} = 40$), and True Negatives ($\\mathrm{TN} = 760$).\n\nLet $D^+$ denote the event that an individual has the condition (disease present), and $D^-$ denote the event that an individual does not have the condition (disease absent), as determined by the reference standard. Let $T^+$ denote a positive test result and $T^-$ denote a negative test result.\n\nThe total number of individuals with the condition is the sum of true positives and false negatives:\n$$N_{D^+} = \\mathrm{TP} + \\mathrm{FN} = 180 + 20 = 200$$\nThe total number of individuals without the condition is the sum of false positives and true negatives:\n$$N_{D^-} = \\mathrm{FP} + \\mathrm{TN} = 40 + 760 = 800$$\n\nThe four operating characteristics are defined as conditional probabilities:\n\n1.  **Sensitivity ($\\mathrm{Se}$)**, also known as the True Positive Rate ($\\mathrm{TPR}$), is the probability of a positive test result given that the individual has the condition. It measures the test's ability to correctly identify those with the disease.\n    $$\\mathrm{Se} = P(T^+ | D^+) = \\frac{\\mathrm{TP}}{\\mathrm{TP} + \\mathrm{FN}}$$\n    Substituting the given values:\n    $$\\mathrm{Se} = \\frac{180}{200} = 0.9$$\n    Rounded to four significant figures, $\\mathrm{Se} = 0.9000$.\n\n2.  **Specificity ($\\mathrm{Sp}$)**, also known as the True Negative Rate ($\\mathrm{TNR}$), is the probability of a negative test result given that the individual does not have the condition. It measures the test's ability to correctly identify those without the disease.\n    $$\\mathrm{Sp} = P(T^- | D^-) = \\frac{\\mathrm{TN}}{\\mathrm{FP} + \\mathrm{TN}}$$\n    Substituting the given values:\n    $$\\mathrm{Sp} = \\frac{760}{800} = 0.95$$\n    Rounded to four significant figures, $\\mathrm{Sp} = 0.9500$.\n\n3.  **False Positive Rate ($\\mathrm{FPR}$)**, also known as the type I error rate, is the probability of a positive test result given that the individual does not have the condition. It is the complement of specificity.\n    $$\\mathrm{FPR} = P(T^+ | D^-) = \\frac{\\mathrm{FP}}{\\mathrm{FP} + \\mathrm{TN}} = 1 - \\mathrm{Sp}$$\n    Substituting the given values:\n    $$\\mathrm{FPR} = \\frac{40}{800} = 0.05$$\n    Rounded to four significant figures, $\\mathrm{FPR} = 0.05000$.\n\n4.  **False Negative Rate ($\\mathrm{FNR}$)**, also known as the type II error rate, is the probability of a negative test result given that the individual has the condition. It is the complement of sensitivity.\n    $$\\mathrm{FNR} = P(T^- | D^+) = \\frac{\\mathrm{FN}}{\\mathrm{TP} + \\mathrm{FN}} = 1 - \\mathrm{Se}$$\n    Substituting the given values:\n    $$\\mathrm{FNR} = \\frac{20}{200} = 0.1$$\n    Rounded to four significant figures, $\\mathrm{FNR} = 0.1000$.\n\n### Interpretation and Trade-off Analysis\nThe computed rates reveal the performance trade-offs of this rapid test.\n\n-   A sensitivity of $\\mathrm{Se} = 0.9000$ means the test correctly identifies $90\\%$ of all individuals who have the condition. Consequently, the false negative rate of $\\mathrm{FNR} = 0.1000$ signifies that $10\\%$ of individuals with the condition are missed by the test. These are the \"missed cases\" who are falsely reassured they are disease-free, which can lead to delayed diagnosis and treatment.\n\n-   A specificity of $\\mathrm{Sp} = 0.9500$ means the test correctly identifies $95\\%$ of all individuals who do not have the condition. Consequently, the false positive rate of $\\mathrm{FPR} = 0.05000$ signifies that $5\\%$ of individuals without the condition receive a false positive result. These individuals are subjected to \"unnecessary follow-up,\" which may involve more invasive, costly, and anxiety-inducing confirmatory tests.\n\nThe trade-off is between minimizing missed cases (maximizing $\\mathrm{Se}$, minimizing $\\mathrm{FNR}$) and minimizing unnecessary follow-up (maximizing $\\mathrm{Sp}$, minimizing $\\mathrm{FPR}$). For a given test technology, increasing sensitivity often leads to a decrease in specificity, and vice versa. In this example, the test is highly specific ($\\mathrm{Sp}=0.9500$), indicating it is very good at ruling out the disease in healthy individuals, thus keeping the rate of false alarms low. Its sensitivity is also high ($\\mathrm{Se}=0.9000$), but not as high as its specificity, indicating a small but non-zero proportion of actual cases will be missed. The choice of this balance depends on the specific clinical context: the severity of the disease, the risks of a missed diagnosis, and the cost and risk of follow-up procedures for false positives.",
            "answer": "$$\\boxed{\\begin{pmatrix} 0.9000  0.9500  0.05000  0.1000 \\end{pmatrix}}$$"
        },
        {
            "introduction": "While sensitivity and specificity describe a test's intrinsic properties, their real-world value depends on the prevalence of the disease in the population being tested. This next practice  explores this crucial relationship by calculating the positive predictive value ($\\mathrm{PPV}$) for a test in a low-prevalence scenario. You will uncover why even a test with excellent $\\mathrm{Se}$ and $\\mathrm{Sp}$ can yield a surprisingly low $\\mathrm{PPV}$, a phenomenon known as the base-rate fallacy, and consider its profound implications for clinical counseling.",
            "id": "4573903",
            "problem": "A national screening program for a rare, asymptomatic condition considers a laboratory assay whose sensitivity ($\\mathrm{Se}$) and specificity ($\\mathrm{Sp}$) have been validated in clinical trials. Let the target condition be denoted by $D$, and a positive test result by $+$. Assume the population prevalence is $P(D)=0.001$, sensitivity is $\\mathrm{Se}=0.95$, and specificity is $\\mathrm{Sp}=0.99$. Using only fundamental definitions from probability theory—specifically, the meaning of conditional probability and the law of total probability—compute the positive predictive value (PPV), defined as $P(D\\,|\\, +)$, for a randomly selected individual who has a single positive screening result. Express your final numerical answer as a decimal and round to four significant figures.\n\nThen, starting from the same fundamental base (definitions of conditional probability and the law of total probability), explain why this value illustrates the base-rate fallacy in the clinical interpretation of test results for low-prevalence conditions, and articulate two concrete counseling points that a preventive medicine clinician should provide to an asymptomatic individual with a single positive screening result in this context. Your interpretive discussion does not need to be quantified, but it must be logically supported by the probabilistic framework.",
            "solution": "The problem asks for the computation and interpretation of the positive predictive value (PPV) of a screening test. The PPV is defined as the conditional probability $P(D\\,|\\, +)$, where $D$ denotes the presence of the disease and $+$ denotes a positive test result. We are required to derive this quantity using fundamental definitions of probability.\n\nThe givens are:\nThe prevalence of the condition, $P(D) = 0.001$.\nThe sensitivity of the test, $\\mathrm{Se} = P(+\\,|\\, D) = 0.95$.\nThe specificity of the test, $\\mathrm{Sp} = P(-\\,|\\, D^c) = 0.99$, where $D^c$ is the complement of $D$ (no disease) and $-$ is a negative test result.\n\nThe definition of conditional probability states that for any two events $A$ and $B$, $P(A\\,|\\, B) = \\frac{P(A \\cap B)}{P(B)}$. Applying this to the PPV, we have:\n$$P(D\\,|\\, +) = \\frac{P(D \\cap +)}{P(+)}$$\nThe numerator, $P(D \\cap +)$, is the joint probability of having the disease and testing positive. We can re-express this using the definition of sensitivity. From $\\mathrm{Se} = P(+\\,|\\, D) = \\frac{P(D \\cap +)}{P(D)}$, we can write:\n$$P(D \\cap +) = P(+\\,|\\, D) \\cdot P(D) = \\mathrm{Se} \\cdot P(D)$$\nThis is the probability of a true positive result.\n\nThe denominator, $P(+)$, is the overall probability of a positive test result in the population. To find this, we use the law of total probability. The population can be partitioned into two mutually exclusive and exhaustive groups: those with the disease ($D$) and those without the disease ($D^c$). Therefore, the probability of a positive test can be written as the sum of the probabilities of a positive test in each of these groups:\n$$P(+) = P(+ \\cap D) + P(+ \\cap D^c)$$\nWe have already expressed the first term, $P(+ \\cap D)$. The second term, $P(+ \\cap D^c)$, represents the probability of a false positive result. We can express this term using conditional probability:\n$$P(+ \\cap D^c) = P(+\\,|\\, D^c) \\cdot P(D^c)$$\nWe are given the specificity, $\\mathrm{Sp} = P(-\\,|\\, D^c) = 0.99$. Since a test result can only be positive or negative for a given state, we have $P(+\\,|\\, D^c) + P(-\\,|\\, D^c) = 1$. Thus, the probability of a positive test in a disease-free individual is:\n$$P(+\\,|\\, D^c) = 1 - P(-\\,|\\, D^c) = 1 - \\mathrm{Sp}$$\nThe probability of not having the disease is the complement of the prevalence:\n$$P(D^c) = 1 - P(D)$$\nSubstituting these back into the expression for $P(+)$, we get:\n$$P(+) = (\\mathrm{Se} \\cdot P(D)) + ((1 - \\mathrm{Sp}) \\cdot (1 - P(D)))$$\nNow we assemble the full expression for the PPV, which is a form of Bayes' theorem:\n$$P(D\\,|\\, +) = \\frac{\\mathrm{Se} \\cdot P(D)}{(\\mathrm{Se} \\cdot P(D)) + ((1 - \\mathrm{Sp}) \\cdot (1 - P(D)))}$$\nSubstituting the given numerical values:\n$P(D) = 0.001$\n$\\mathrm{Se} = 0.95$\n$\\mathrm{Sp} = 0.99$\n\nThe probability of a true positive is:\n$$P(\\text{True Positive}) = \\mathrm{Se} \\cdot P(D) = 0.95 \\times 0.001 = 0.00095$$\nThe probability of a false positive is:\n$$P(\\text{False Positive}) = (1 - \\mathrm{Sp}) \\cdot (1 - P(D)) = (1 - 0.99) \\times (1 - 0.001) = 0.01 \\times 0.999 = 0.00999$$\nThe total probability of a positive test is the sum of these two probabilities:\n$$P(+) = 0.00095 + 0.00999 = 0.01094$$\nFinally, the positive predictive value is:\n$$P(D\\,|\\, +) = \\frac{0.00095}{0.01094} \\approx 0.08683729...$$\nRounding to four significant figures, we get $0.08684$.\n\nThis result clearly illustrates the base-rate fallacy. The fallacy is the cognitive error of focusing on individuating information (the specific test, with its high sensitivity of $95\\%$ and specificity of $99\\%$) while ignoring the base-rate information (the very low prevalence of $0.001$). A person might intuitively, but incorrectly, believe that a positive result from a $95\\%$ sensitive test means there is a $95\\%$ chance they have the disease. Our calculation shows the actual probability is less than $9\\%$. The reason for this counter-intuitive result is embedded in the calculation of $P(+)$. The number of false positives (from the large healthy population, $99.9\\%$) vastly outnumbers the number of true positives (from the small diseased population, $0.1\\%$). Specifically, the probability of a false positive ($0.00999$) is more than ten times the probability of a true positive ($0.00095$). Therefore, among all individuals who test positive, the vast majority are actually disease-free.\n\nA preventive medicine clinician should provide clear, contextualized counseling to an asymptomatic individual with such a result. Two concrete counseling points would be:\n\n1.  \"This positive screening result does not mean you have been diagnosed with the condition. In fact, based on this test alone, the probability that you actually have this rare condition is less than $1$ in $10$. The vast majority of people who receive a positive result on this initial test turn out to be what we call 'false positives'.\" This directly addresses the low PPV, manages immediate anxiety, and corrects the common misinterpretation of the test result.\n\n2.  \"What this result does mean is that you are no longer in the low-risk general population, and further investigation is necessary. This screening test has done its job by identifying a smaller group of individuals who require a more definitive diagnostic test. Our next step will be to schedule this follow-up test, which will give us a much clearer answer.\" This point reframes the positive result as a successful risk stratification step, not a final diagnosis, and provides a clear, actionable plan, which helps to channel the patient's concern into productive action.",
            "answer": "$$\n\\boxed{0.08684}\n$$"
        },
        {
            "introduction": "Sensitivity and specificity are not always static; for many tests based on continuous measurements, they exist in a dynamic trade-off controlled by a decision threshold. This final exercise  simulates the process of adjusting a test's threshold to increase its sensitivity for detecting a disease. By calculating the resulting changes, you will directly observe and quantify the core principle that increasing sensitivity often comes at the cost of decreasing specificity, a central challenge in designing and optimizing any screening strategy.",
            "id": "4573893",
            "problem": "A public health team is evaluating a continuous biomarker used as a screening test for a chronic disease in a high-risk population of $10{,}000$ adults. A definitive reference method (gold standard) identifies $1{,}000$ individuals with the disease and $9{,}000$ without the disease. At a particular decision threshold, the test yields the following classification counts relative to the gold standard: $680$ True Positives ($\\mathrm{TP}$), $320$ False Negatives ($\\mathrm{FN}$), $450$ False Positives ($\\mathrm{FP}$), and $8{,}550$ True Negatives ($\\mathrm{TN}$). The team considers lowering the decision threshold to classify more borderline results as positive. They hypothesize that this will reclassify $50$ individuals who were previously $\\mathrm{FN}$ into $\\mathrm{TP}$, and simultaneously reclassify $100$ individuals who were previously $\\mathrm{TN}$ into $\\mathrm{FP}$. \n\nUsing the core definitions of sensitivity ($\\mathrm{Se}$) and specificity ($\\mathrm{Sp}$) in terms of conditional probabilities of test results given disease status, compute the new $\\mathrm{Se}$ and $\\mathrm{Sp}$ after this reclassification. Express your final answer as a row matrix containing the new $\\mathrm{Se}$ and the new $\\mathrm{Sp}$, in that order, using exact fractions (do not round). No units are required.",
            "solution": "The core definitions of sensitivity ($\\mathrm{Se}$) and specificity ($\\mathrm{Sp}$) are formulated in terms of the counts of true positives ($\\mathrm{TP}$), false negatives ($\\mathrm{FN}$), false positives ($\\mathrm{FP}$), and true negatives ($\\mathrm{TN}$).\n\nSensitivity is the probability that a test correctly identifies an individual with the disease. It is the ratio of true positives to the total number of individuals who actually have the disease.\n$$ \\mathrm{Se} = \\frac{\\mathrm{TP}}{\\mathrm{TP} + \\mathrm{FN}} $$\n\nSpecificity is the probability that a test correctly identifies an individual without the disease. It is the ratio of true negatives to the total number of individuals who are actually free of the disease.\n$$ \\mathrm{Sp} = \\frac{\\mathrm{TN}}{\\mathrm{TN} + \\mathrm{FP}} $$\n\nThe total number of diseased individuals is given as $1,000$. This number is fixed, as it is determined by the gold standard reference method, not the screening test's threshold. Thus, the denominator for sensitivity is constant:\n$$ \\mathrm{TP} + \\mathrm{FN} = 1,000 $$\n\nSimilarly, the total number of non-diseased individuals is given as $9,000$. This denominator for specificity is also constant:\n$$ \\mathrm{TN} + \\mathrm{FP} = 9,000 $$\n\nThe initial counts are:\n- $\\mathrm{TP}_{initial} = 680$\n- $\\mathrm{FN}_{initial} = 320$\n- $\\mathrm{FP}_{initial} = 450$\n- $\\mathrm{TN}_{initial} = 8,550$\n\nThe problem states that lowering the decision threshold causes a reclassification. We must determine the new counts, denoted with the subscript 'new'.\n\n1.  Reclassification of diseased individuals: $50$ individuals who were previously false negatives ($\\mathrm{FN}$) are now reclassified as true positives ($\\mathrm{TP}$).\n    - The number of $\\mathrm{TP}$ increases by $50$: $\\mathrm{TP}_{new} = \\mathrm{TP}_{initial} + 50 = 680 + 50 = 730$.\n    - The number of $\\mathrm{FN}$ decreases by $50$: $\\mathrm{FN}_{new} = \\mathrm{FN}_{initial} - 50 = 320 - 50 = 270$.\n    - The total number of diseased individuals remains unchanged: $\\mathrm{TP}_{new} + \\mathrm{FN}_{new} = 730 + 270 = 1,000$.\n\n2.  Reclassification of non-diseased individuals: $100$ individuals who were previously true negatives ($\\mathrm{TN}$) are now reclassified as false positives ($\\mathrm{FP}$).\n    - The number of $\\mathrm{FP}$ increases by $100$: $\\mathrm{FP}_{new} = \\mathrm{FP}_{initial} + 100 = 450 + 100 = 550$.\n    - The number of $\\mathrm{TN}$ decreases by $100$: $\\mathrm{TN}_{new} = \\mathrm{TN}_{initial} - 100 = 8,550 - 100 = 8,450$.\n    - The total number of non-diseased individuals remains unchanged: $\\mathrm{TN}_{new} + \\mathrm{FP}_{new} = 8,450 + 550 = 9,000$.\n\nNow, we compute the new sensitivity ($\\mathrm{Se}_{new}$) and new specificity ($\\mathrm{Sp}_{new}$) using the new counts.\n\nFor the new sensitivity:\n$$ \\mathrm{Se}_{new} = \\frac{\\mathrm{TP}_{new}}{\\mathrm{TP}_{new} + \\mathrm{FN}_{new}} = \\frac{730}{1,000} $$\nAs an exact fraction, this simplifies to:\n$$ \\mathrm{Se}_{new} = \\frac{73}{100} $$\n\nFor the new specificity:\n$$ \\mathrm{Sp}_{new} = \\frac{\\mathrm{TN}_{new}}{\\mathrm{TN}_{new} + \\mathrm{FP}_{new}} = \\frac{8,450}{9,000} $$\nTo simplify this fraction, we can divide the numerator and denominator by common factors.\n$$ \\mathrm{Sp}_{new} = \\frac{8,450}{9,000} = \\frac{845}{900} $$\nBoth numbers are divisible by $5$:\n$$ 845 \\div 5 = 169 $$\n$$ 900 \\div 5 = 180 $$\nThus, the simplified fraction is:\n$$ \\mathrm{Sp}_{new} = \\frac{169}{180} $$\nThe number $169$ is $13^2$. The prime factorization of $180$ is $2^2 \\times 3^2 \\times 5$. There are no common factors, so the fraction is in its simplest form.\n\nThe new sensitivity is $\\frac{73}{100}$ and the new specificity is $\\frac{169}{180}$. The final answer is to be expressed as a row matrix.",
            "answer": "$$\n\\boxed{\\begin{pmatrix} \\frac{73}{100}  \\frac{169}{180} \\end{pmatrix}}\n$$"
        }
    ]
}